Trial intelligence / Profile preview

TAP vs EOIB Block for Post-Laparoscopic Cholecystectomy Pain

NCT06178757Completed

Sponsor
Istanbul Medipol University
Start
Dec 2023
Primary completion
Jul 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Istanbul Medipol University. Primary endpoint: Global recovery scoring system (patient satisfaction scale) at 24 hours. Started Dec 2023; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06178757.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06178757.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call